Annual Meeting

In its 15th year, CIMT will host two meetings for the cancer immunotherapy community:

2017 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
September 6-8, 2017
Mainz, Germany

and, as a special event for CIMT members, the

15th CIMT Annual Meeting
"Members Symposium"
May 10 – 11, 2017 | Mainz, Germany


14th CIMT Annual Meeting

Europe’s largest meeting focused on cancer immunotherapy research and development
 May 10 – 12, 2016 | Mainz, Germany

CIMT Satellites

CIMT actively participates in international cancer and immunology meetings by sponsoring sessions and workshops dedicated to the topic of cancer immunotherapy.

AACR-CIMM-CIMT Joint Session on Immune-Informatics and the Tumor Microenvironment to Boost Cancer Immunotherapy at 2015 AACR Annual Meeting 

April 21, 2015, 3:00-5:00 p.m., Pennsylvania Convention Center/Philadelphia, PA


Cedrik M. Britten. Glaxo-Smith Kline, Stevenage, UK; 
Sjoerd H. van der Burg. Leiden Univ. Medical Ctr., Leiden, Netherlands

"Characterization of cancer immunophenotypes and antigenomes using NGSdata and bionformatics methods "

Zlatko Trajanoski. Innsbruck Medical University, Innsbruck, Austria

"The role of the p53 protein in epigenetic regulation and the innate immune response"
Arnold J. Levine. Institute for Advanced Study, Princeton, NJ

"Building effective immunotherapy: lessons from ovarian cancer"
George Coukos. Ludwig Cancer Research Center, Lausanne, Switzerland

"An integrative network approach for genomic discovery and personalized therapy in relapsed multiple myeloma"
Joel Dudley. Icahn School of Medicine at Mount Sinai, New York, NY

CIMT Endeavour

4th CIMT Endeavour Workshop - Translating cancer science into products and companies

May 11, 2016 from 08:30-12:00 at Rheingoldhalle Congress Center in Mainz, Germany

To learn more, please go to

Endeavour is a CIMT activity focusing on the translation and commercialization of cancer immunotherapies and diagnostics.
The 2016 workshop will allow scientists from the cancer immunotherapy community to present their innovation to business experts and venture capital representatives with a focus on funding initiatives, viable business models and product development. Participants will share and discuss the challenges that European and American biotech companies face in early, middle and late stage development.

The 2016 workshop is open to the attendees of the 2016 CIMT Annual Meeting at no extra charge. However, as spaces are limited, workshop registration is required. To register, please go to

Participants not registered for the Annual Meeting will have to pay a workshop fee in the amount of 50 EUR. Please contact for registration or more information.

CIMT Endeavour 2016 is organized in cooperation with Ci3 and Oslo Cancer Cluster and supported by the German Federal Ministry of Education and Research.


Endeavour Workshop Impressions 2015

Joint Meeting

Translating Science into Survival
September 25-28, 2016, New York, NY

The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to once again join forces to sponsor the International Cancer Immunotherapy Conference, which will take place in New York City from September 25-28, 2016. 

Entitled “Translating Science into Survival,” the meeting will feature more than 60 talks by acknowledged leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy.

This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.  


•    Abstract submission deadline is June 16, 2016. 
•    Advance registration deadline is August 8, 2016. 

Email, or visit

Meeting Co-Chairs:

• James P. Allison, The University of Texas MD Anderson Cancer Center
• Philip D. Greenberg, Fred Hutchinson Cancer Research Center and University of Washington
• Christoph Huber, CIMT
• Guido Kroemer, Institut Gustave Roussy

Planning Committee Members:
• Wolf Fridman, Centre de Recherche des Cordeliers
• Axel Hoos, GlaxoSmithKline
• Elizabeth M. Jaffee, Johns Hopkins Kimmel Comprehensive Cancer Center
• Peter W.M. Johnson, Cancer Research UK Centre Southampton General Hospital
• Cornelis J.M. Melief, Leiden University Medical Center & ISA Pharmaceuticals
• Ira Mellman, Genentech, Inc.
• Ellen Puré, University of Pennsylvania
• Catherine Sautés-Fridman, Universite Paris-Descartes
• Drew Pardoll, Johns Hopkins Kimmel Comprehensive Cancer Center
• Robert D. Schreiber, Washington University School of Medicine
• Ozlem Tureci, Ganymed Pharmaceuticals
• E. John Wherry, University of Pennsylvania
• Theresa L. Whiteside, University of Pittsburgh Cancer Institute
• Laurence Zitvogel, Institut Gustave Roussy






CLINAM 9 / 2016 Conference and Exhibition 

European & Global Summit for Cutting-Edge Medicine

June 26 – 29, 2016,  Basel

Clinical Nanomedicine and Targeted Medicine 

Enabling Technologies for Personalized Medicine


Immuno-Oncology 360°

February 2-3, 2016
New York Academy of Medicine, New York, New York

The 2nd annual Immuno-Oncology 360° is the only conference that combines business and clinical development strategies with scientific updates to prepare the market for accelerating immuno-oncology (IO) clinical trials. With the support of the Cancer Research Institute (CRI), The Society for Immunotherapy of Cancer (SITC) and The Association for Cancer Immunotherapy (CIMT), this conference attracts national and international experts and thought leaders from large pharma, biotech, investment community, academia and research organizations as part of the speaking faculty and attendees. 



Get the CIMT newsletter

Subscribe to CIMT newsletter